Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: J Comp Neurol. 2023 Jul 21;531(14):1459–1481. doi: 10.1002/cne.25525

Figure 2. Retrograde tracer into AuD labels cell bodies in OFC.

Figure 2.

a. Schematic of all injection sites in left AuD (N = 3). Plate references from anterior to posterior: 33, 34 (Radtke-Schuller et al., 2016). b. Injection site of representative subject. Scale bar = 1000 μm. c. In the same subject as in B, expected labeling observed in contralateral AuD. Scale bar = 500 μm, inset =100 μm. d. Labeled OFC cell bodies in the same subject as B. High magnification images depict cell bodies in the ipsilateral (left) and contralateral (right) OFC. Scale bar = 500 μm, high-mag = 100 μm. e. Proportion of total labeled cells in each hemisphere. Bars represent means ± standard error; lines connect data points from individual animals. f. Proportion of cell bodies within the ipsilateral hemisphere localized to each OFC subregion. Bars represent means ± standard error. *p<0.05